Biosimulation Market Size, Share, and Analysis, By Product (Software, Services), By Application (Drug Discovery, Disease Modelling, and Others), By Therapeutic Area (Oncology, Cardiovascular Disease, Infectious Disease, Neurological Disorders, and Others)
Description
The global atomic layer deposition (ALD) market forecast 2024-2034 with size, CAGR of 12.5%, key products, applications & regional insights.
*Please Note: The report will be delivered in 2-3 business days upon order confirmation*
*Please Note: The report will be delivered in 2-3 business days upon order confirmation*
Table of Contents
397 Pages
- Executive Summary
- Regional Market Share
- Business Trends
- Biosimulation Market: COVID-19 Outbreak
- Regional Trends
- Segmentation Snapshot
- Research Methodology
- Research Objective
- Research Approach
- Data Sourcing and Methodology
- Primary Research
- Secondary Research
- Paid Sources
- Public Sources
- Market Size Estimation and Data Triangulation
- Market Characteristics
- Market Definition
- Biosimulation Market: COVID-19 Impact
- Key Segmentations
- Key Developments
- Allied Industry Data
- Biosimulation Market– Industry Insights
- Industry Segmentation
- COVID-19 overview on world economy
- Industry ecosystem Channel analysis
- Innovation & Sustainability
- Macroeconomic Indicators
- Recent Developments
- Market Dynamics
- Introduction
- Growth Drivers
- Market Opportunities
- Market Restraints
- Market Trends
- Risk Analysis
- Market Analysis
- Porters Five Forces
- PEST Analysis
- Political
- Economic
- Social
- Technological
- Biosimulation Market
- Overview
- Historical Analysis (2019-2022)
- Market Size, Y-o-Y Growth (%) and Market Forecast
- Biosimulation Market Size & Forecast 2024A-2034F
- Overview
- Key Findings
- Market Segmentation
- By Product
- Software
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Services
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- By Application
- Drug Discovery
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Disease Modelling
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Others
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- By Therapeutic Area
- Oncology
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Cardiovascular Disease
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Infectious Disease
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Neurological Disorders
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Others
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- By Deployment Mode
- Cloud-based
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- On-Premise
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Hybrid Model
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- By Pricing Model
- License-based Model
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Subscription-based Model
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Hybrid Model
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- By End User
- Contact Research Organizations
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Pharmaceutical & Biotechnology Companies
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Regulatory Authorities
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- Academic Research Insitutues
- By Value (USD Million) 2024-2034F
- Market Share (%) 2024-2034F
- Y-o-Y Growth (%) 2024-2034F
- North AmericaBiosimulation Market Size & Forecast 2024A-2034F
- Overview
- Key Findings
- Market Segmentation
- By Product
- By Application
- By Deployment Mode
- By Pricing Model
- By End User
- Country
- United States
- Canada
- EuropeBiosimulation MarketSize & Forecast 2024A-2034F
- Overview
- Key Findings
- Market Segmentation
- By Product
- By Application
- By Deployment Mode
- By Pricing Model
- By End User
- Country
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- Asia-PacificBiosimulation MarketSize & Forecast 2024A-2034F
- Overview
- Key Findings
- Market Segmentation
- By Product
- By Application
- By Deployment Mode
- By Pricing Model
- By End User
- Country
- India
- China
- South Korea
- Japan
- Rest of APAC
- Middle East and AfricaBiosimulation MarketSize & Forecast 2024A-2034F
- Overview
- Key Findings
- Market Segmentation
- By Product
- By Application
- By Deployment Mode
- By Pricing Model
- By End User
- Country
- Israel
- GCC
- North Africa
- South Africa
- Rest of Middle East and Africa
- Latin AmericaBiosimulation MarketSize & Forecast 2024A-2034F
- Overview
- Key Findings
- Market Segmentation
- By Product
- By Application
- By Deployment Mode
- By Pricing Model
- By End User
- Country
- Mexico
- Brazil
- Rest of Latin America
- Competitive Landscape
- Company market share, 2023
- Key player overview
- Key stakeholders
- Company Profiles
- Certara, Inc.
- Company Overview
- Financial Overview
- Key Product; Analysis
- Company Assessment
- Product Portfolio
- Key Clients
- Market Share
- Recent News & Development (Last 3 Yrs.)
- Executive Team
- Simulation Plus, Inc.
- Schrödinger, Inc.
- Dassault Systèmes
- Advanced Chemistry Development (ACD/Labs)
- Rosa & Co. LLC
- Chemical Computing Group ULC
- Genedata AG
- Insilico Biotechnology AG
- Evidera, Inc.
- Leadscope, Inc.
- BioSimulation Consulting Inc.
- Nuventra Pharma Sciences
- CertusBio
- Physiomics PLC
- Other Prominent Players
- Appendix
- Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



